Vistagen Therapeutics (VTGN) Q3 2025 Earnings

7AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.51
-0.47
-0.43
-0.39

Details

Expected EPS
-0.473333
Actual EPS
-0.47
Surprise EPS
0
Surprise Percent
+0.7%

Description

Vistagen Therapeutics (VTGN) has reported earnings of -0.47 per share for Q3 2025.

0 Comments

Share your thoughts